INFU — InfuSystems Holdings Inc

InfuSystems Holdings Inc (INFU) is a medical devices company listed on AMEX. It is led by Carrie A. Lachance B.S.N., M.B.A., R.N., based in 3851 West Hamlin Road, Rochester Hills, MI, United States, 48309, with about 461 employees. InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, the company offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Latest reported INFU revenue for 2025-09-30 was $36.5M. Net income was $2.3M. Revenue was up 1.3% from 2025-06-30 to 2025-09-30. INFU currently screens at market cap $186.5M and trailing P/E 25.0.

Use this INFU page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the INFU quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the INFU SEC filings page. Lician reads the product cache first so this HTML stays unique to InfuSystems Holdings Inc even when a live quote feed is slow.